Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators

Chatzopoulou M, Emer E, Lecci C, Rowley JA, Casagrande A-S, Moir L, Squire SE, Davies SG, Harriman S, Wynne GM, Wilson FX, Davies KE

et al

10 December 2020

Journal article

Journal:

ACS Medicinal Chemistry Letters

Volume:

Issue:

American Chemical Society (ACS)

pp.

2421 - 2427

No abstract available

Keywords:

3404 Medicinal and Biomolecular Chemistry

34 Chemical Sciences

Muscular Dystrophy

Rare Diseases

Orphan Drug

5.1 Pharmaceuticals

DOI